J. . Oldenburg, “Real-world clinical experience of extended half-life recombinant factor VIII Fc fusion protein (rFVIIIFc) in comparison to conventional factor products in patients with severe hemophilia A ”, J Current Med Res Opinion, vol. 4, no. 05, pp. 950–960, May 2021.